CircKDM1B played a critical role in HCC progression by regulating cell proliferation, migration, invasion and apoptosis. CircKDM1B/miR-1322/PRC1 axis might be a novel therapeutic target of HCC patients.
CircKDM1B promotes hepatocellular carcinoma progression through regulating miR-1322/PRC1 axis.